PELP1 cytoplasmic mislocalization favors estrogen-induced signaling via AIB1 in ER+ breast cancer models

被引：0
|
作者：
Truong, Thu H.
Ostrander, Julie H.
Lange, Carol A.
机构：
来源：
CANCER RESEARCH | 2017年 / 77卷
关键词：
D O I：
10.1158/1538-7445.AM2017-3618
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
3618
引用
收藏
页数：2
相关论文
共 50 条
  • [1] PELP1 and AIB1 cooperate to promote breast cancer progression in ER plus breast cancer models.
    Truong, Thu H.
    Hu, Hsiangyu
    Ostrander, Julie H.
    Lange, Carol A.
    MOLECULAR CANCER RESEARCH, 2018, 16 (08) : 40 - 41
  • [2] Cancer Stem Cell Phenotypes in ERthorn Breast Cancer Models Are Promoted by PELP1/AIB1 Complexes
    Truong, Thu H.
    Hu, Hsiangyu
    Temiz, Nuri A.
    Hagen, Kyla M.
    Girard, Brian J.
    Brady, Nicholas J.
    Schwertfeger, Kathryn L.
    Lange, Carol A.
    Ostrander, Julie H.
    MOLECULAR CANCER RESEARCH, 2018, 16 (04) : 707 - 719
  • [3] PELP1 and AIB1 (SRC-3) complexes promote cancer stem cell-associated phenotypes in ER plus breast cancer models
    Truong, Thu H.
    Hu, Hsiangyu
    Temiz, Nuri A.
    Hagen, Kyla M.
    Girard, Brian J.
    Brady, Nicholas J.
    Schwertfeger, Kathryn L.
    Lange, Carol A.
    Ostrander, Julie H.
    CANCER RESEARCH, 2018, 78 (13)
  • [4] Cytoplasmic PELP1 promotes breast cancer initiation via NF-κB signaling
    Ostrander, Julie H.
    Girard, Brian J.
    Knutson, Todd
    Kuker, Bethanie
    Seewaldt, Victoria
    CANCER RESEARCH, 2015, 75
  • [5] Significance of PELP1 in ER-Negative Breast Cancer Metastasis
    Roy, Sudipa
    Chakravarty, Dimple
    Cortez, Valerie
    De Mukhopadhyay, Keya
    Bandyopadhyay, Abhik
    Ahn, Jung-Mo
    Raj, Ganesh V.
    Tekmal, Rajeshwar R.
    Sun, LuZhe
    Vadlamudi, Ratna K.
    MOLECULAR CANCER RESEARCH, 2012, 10 (01) : 25 - 33
  • [6] Estrogens Correlate with PELP1 Expression in ER Positive Breast Cancer
    Flageng, Marianne Hauglid
    Knappskog, Stian
    Gjerde, Jennifer
    Lonning, Per Eystein
    Mellgren, Gunnar
    PLOS ONE, 2015, 10 (08):
  • [7] PELP1/SRC-3-dependent regulation of metabolic PFKFB kinases drives therapy resistant ER+ breast cancer
    Thu H. Truong
    Elizabeth A. Benner
    Kyla M. Hagen
    Nuri A. Temiz
    Carlos Perez Kerkvliet
    Ying Wang
    Emilio Cortes-Sanchez
    Chieh-Hsiang Yang
    Marygrace C. Trousdell
    Thomas Pengo
    Katrin P. Guillen
    Bryan E. Welm
    Camila O. Dos Santos
    Sucheta Telang
    Carol A. Lange
    Julie H. Ostrander
    Oncogene, 2021, 40 : 4384 - 4397
  • [8] Expression of estrogen receptor co-activator AIB1 in breast cancer
    Morimiya, A.
    Turbin, D.
    Hunstman, D.
    Zhang, Q.
    Jeng, M.
    Nakshatri, H.
    Badve, S.
    MODERN PATHOLOGY, 2007, 20 : 42A - 42A
  • [9] Expression of estrogen receptor co-activator AIB1 in breast cancer
    Morimiya, A.
    Turbin, D.
    Hunstman, D.
    Zhang, Q.
    Jeng, M.
    Nakshatri, H.
    Badve, S.
    LABORATORY INVESTIGATION, 2007, 87 : 42A - 42A
  • [10] PELP1/SRC-3-dependent regulation of metabolic PFKFB kinases drives therapy resistant ER+ breast cancer
    Truong, Thu H.
    Benner, Elizabeth A.
    Hagen, Kyla M.
    Temiz, Nuri A.
    Kerkvliet, Carlos Perez
    Wang, Ying
    Cortes-Sanchez, Emilio
    Yang, Chieh-Hsiang
    Pengo, Thomas
    Guillen, Katrin P.
    Welm, Bryan E.
    Telang, Sucheta
    Lange, Carol A.
    Ostrander, Julie H.
    Trousdell, Marygrace C.
    Camila
    ONCOGENE, 2021, 40 (25) : 4384 - 4397
12345